Cleared Traditional

K223710 - i-STAT CG8+ cartridge with the i-STAT 1...

K223710 is an FDA 510(k) clearance for i-STAT CG8+ cartridge with the i-STAT 1..., manufactured by Abbott Point of Care, Inc.. The device is a Class 2 Chemistry device with product code CGA cleared through the Traditional 510(k) pathway after a 228-day FDA review.

K223710 · Abbott Point of Care, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
228d
Days
Class 2
Risk

K223710 is an FDA 510(k) clearance for the i-STAT CG8+ cartridge with the i-STAT 1 System. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Abbott Point of Care, Inc. (Princton, US). The FDA issued a Cleared decision on July 28, 2023 after a review of 228 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Point of Care, Inc. devices

FDA 510(k) Submission Details - K223710

510(k) Number K223710 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2022
Decision Date July 28, 2023
Days to Decision 228 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
140d slower than avg
Panel avg: 88d · This submission: 228d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGA Device Classification - Class 2, Special Controls

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 223
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K223710.
EasyStat 300
K220328 · Medica Corporation · Jul 2024
Cholestech LDX ™ System
K223179 · Alere San Diego, Inc. · Sep 2023
i-STAT G cartridge with the i-STAT 1 System
K223755 · Abbott Point of Care, Inc. · Sep 2023
GEM Premier ChemSTAT
K223090 · Instrumentation Laboratory CO · Jan 2023
Nova Primary Glucose Analyzer System
K203549 · Nova Biomedical Corporation · Oct 2022
i-STAT CHEM8+ cartridge with the i-STAT 1 System
K210958 · Abbott Point of Care, Inc. · Aug 2021